Recruiting PHASE2, PHASE3 Acute Respiratory Distress Syndrome

Tests treatment safety and results for Acute Respiratory Distress Syndrome

Official title A Comparative Study of Glucocorticoids Efficacy in Acute Respiratory Distress Syndrome

ClinicalTrials.gov ID: NCT06496997

What this study is testing

What is Methylprednisolone?

Methylprednisolone is an investigational medicine, being studied as a potential treatment for acute respiratory distress syndrome.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The aim of the work is to compare the efficacy of equivalent doses of methylprednisolone, dexamethasone and hydrocortisone in patients with ARDS
  • Phase 3: a large, late-stage study
  • You might receive a placebo (an inactive treatment) instead of the study drug.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Adults

You may be able to join if

  • We include patients receiving mechanical ventilation for hypoxemic respiratory failure if they met the diagnostic criteria for ARDS according to the...
  • Presence of acute hypoxemic respiratory failure (an arterial oxygen partial pressure to fraction of inspired oxygen ratio (PaO2/FiO2) of ≤ 300 mm Hg...
  • Onset within 7 days of insult, or new (within 7 days) or worsening respiratory symptoms
  • Bilateral opacities on chest x-ray or CT not fully explained by effusions, lobar or lung collapse, or nodules
  • Cardiac failure not the primary cause of acute respiratory failure

You likely can't join if

  • We exclude patients with acute hypoxemic respiratory failure caused by congestive heart failure

The study team makes the final eligibility decision.

Where it's taking place

  • Al Fayyum, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Al Fayyum, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.